Agilent Technologies, Inc.: Form 10-Q for the period ended Jul 31, 2019
Filed with the SEC on Aug 30, 2019 and accepted by EDGAR at Aug 30, 2019, 16:29 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-05-01 to 2019-07-31 | $1.27bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2018-11-01 to 2019-07-31 | $3.80bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2019-05-01 to 2019-07-31 | $582.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2018-11-01 to 2019-07-31 | $1.73bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2019-05-01 to 2019-07-31 | $101.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2018-11-01 to 2019-07-31 | $302.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2019-05-01 to 2019-07-31 | $366.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2018-11-01 to 2019-07-31 | $1.07bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-05-01 to 2019-07-31 | $225.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2018-11-01 to 2019-07-31 | $691.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-05-01 to 2019-07-31 | $18.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2018-11-01 to 2019-07-31 | $53.0m | us-gaap:InterestExpense |
| Income tax | 3 months2019-05-01 to 2019-07-31 | $31.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2018-11-01 to 2019-07-31 | −$189.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-05-01 to 2019-07-31 | $191.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2018-11-01 to 2019-07-31 | $877.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-05-01 to 2019-07-31 | $0.60 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2018-11-01 to 2019-07-31 | $2.74 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-05-01 to 2019-07-31 | $0.61 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2018-11-01 to 2019-07-31 | $2.78 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-05-01 to 2019-07-31 | 316,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2018-11-01 to 2019-07-31 | 320,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2018-11-01 to 2019-07-31 | $707.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2018-11-01 to 2019-07-31 | $125.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2019-05-01 to 2019-07-31 | $51.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Dividends paid | 9 months2018-11-01 to 2019-07-31 | $155.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2018-11-01 to 2019-07-31 | $674.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-07-31 | $1.76bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-07-31 | $3.46bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-07-31 | $8.63bn | us-gaap:Assets |
| Current liabilities | At period end2019-07-31 | $1.62bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-07-31 | $3.88bn | us-gaap:Liabilities |
| Long-term debt | At period end2019-07-31 | $1.29bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2019-07-31 | $504.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2019-07-31 | $4.75bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001090872-19-000015. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.